Three-arm randomized trial of sodium alginate, orally administered mucoprotective agent, for preventing radiation esophagitis in pts with locally advanced non-small-cell lung cancer (LA-NSCLC) receiving concurrent chemoradiotherapy (CRT): Okayama Lung Cancer Study Group 1401.

Abstract

TPS9641 Background: Concurrent CRT is the standard treatment in LA-NSCLC. Our phase 3 trial also showed a favorable efficacy of cisplatin-docetaxel and concurrent thoracic radiotherapy (JCO 2010). ...